NCT01767376 / 2012-002737-11: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age |
|
|
| Completed | 3 | 692 | Europe, RoW | Meningococcal vaccine GSK134612, MenACWY-TT, Nimenrix, Boostrix®, Tdap | GlaxoSmithKline | Infections, Meningococcal | 01/14 | 01/14 | | |
NCT01755689 / 2012-001876-13: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults |
|
|
| Completed | 3 | 1300 | Europe, RoW | Meningococcal vaccine GSK134612, Nimenrix®, Cervarix®, Boostrix® | GlaxoSmithKline | Infections, Meningococcal | 04/14 | 04/14 | | |
